Heterogeneous_JJ
expression_NN
of_IN
the_DT
lipocalin_NN
NGAL_NN
in_IN
primary_JJ
breast_NN
cancers_NNS
._.

We_PRP
have_VBP
previously_RB
shown_VBN
that_IN
neu_NN
oncogene-initiated_JJ
rat_NN
mammary_JJ
carcinomas_NNS
uniquely_RB
over-express_VBP
neu-related_JJ
lipocalin_NN
-LRB-_-LRB-
NRL_NN
-RRB-_-RRB-
,_,
a_DT
member_NN
of_IN
the_DT
calycin_NN
protein_NN
superfamily_NN
._.

Here_RB
,_,
we_PRP
characterize_VBP
the_DT
putative_JJ
human_JJ
homolog_NN
of_IN
NRL_NN
,_,
neutrophil_NN
gelatinase-associated_JJ
lipocalin_NN
-LRB-_-LRB-
NGAL_NN
-RRB-_-RRB-
._.

ngal_JJ
gene_NN
expression_NN
was_VBD
found_VBN
at_IN
moderate_JJ
levels_NNS
in_IN
only_RB
2_CD
of_IN
17_CD
human_JJ
tissues_NNS
examined_VBN
,_,
breast_NN
and_CC
lung_NN
._.

When_WRB
breast_NN
cancers_NNS
were_VBD
examined_VBN
for_IN
NGAL_NN
mRNA_NN
and_CC
protein_NN
levels_NNS
,_,
they_PRP
were_VBD
found_VBN
to_TO
exhibit_VB
heterogeneous_JJ
expression_NN
._.

NGAL_NN
levels_NNS
varied_VBD
in_IN
these_DT
tumors_NNS
from_IN
undetectable_JJ
to_TO
exceeding_VBG
those_DT
in_IN
normal_JJ
breast_NN
parenchyma_NN
._.

Immuno-histochemical_JJ
analysis_NN
confirmed_VBD
the_DT
presence_NN
of_IN
NGAL_NN
within_IN
breast_NN
carcinoma_NN
cells_NNS
but_CC
detected_VBD
only_RB
low_JJ
levels_NNS
of_IN
this_DT
protein_NN
in_IN
normal_JJ
ductal_JJ
epithelium_NN
._.

In_IN
contrast_NN
,_,
large_JJ
amounts_NNS
of_IN
the_DT
protein_NN
were_VBD
localized_JJ
to_TO
the_DT
lumen_NN
of_IN
normal_JJ
breast_NN
ducts_NNS
in_IN
the_DT
vicinity_NN
of_IN
NGAL-expressing_JJ
tumors_NNS
._.

Interestingly_RB
,_,
unlike_IN
NRL_NN
in_IN
rat_NN
mammary_JJ
carcinomas_NNS
,_,
no_DT
significant_JJ
association_NN
between_IN
NGAL_NN
expression_NN
and_CC
HER-2_NN
\/_:
neu_NN
activation_NN
was_VBD
found_VBN
in_IN
human_JJ
breast_NN
tumors_NNS
._.

In_IN
contrast_NN
,_,
a_DT
significant_JJ
correlation_NN
between_IN
NGAL_NN
expression_NN
in_IN
breast_NN
cancer_NN
was_VBD
found_VBN
with_IN
several_JJ
other_JJ
markers_NNS
of_IN
poor_JJ
prognosis_NN
,_,
including_VBG
estrogen_NN
and_CC
progesterone_NN
receptor-negative_JJ
status_NN
and_CC
high_JJ
proliferation_NN
-LRB-_-LRB-
S-phase_NN
fraction_NN
-RRB-_-RRB-
._.

NGAL_NN
levels_NNS
were_VBD
stratified_VBN
as_IN
high_JJ
or_CC
low_JJ
in_IN
breast_NN
cancers_NNS
from_IN
a_DT
cohort_NN
of_IN
node-positive_JJ
patients_NNS
with_IN
known_JJ
outcome_NN
._.

No_DT
significant_JJ
association_NN
between_IN
NGAL_NN
expression_NN
and_CC
disease-free_JJ
or_CC
overall_JJ
survival_NN
was_VBD
observed_VBN
._.

